These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

664 related items for PubMed ID: 17008270

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS, Joo BS, Moon SE, Lee SK, Kim KS, Koo JS.
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, Van Steirteghem A, Devroey P.
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [Abstract] [Full Text] [Related]

  • 7. Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting.
    Ho Yuen B, Nguyen TA, Cheung AP, Leung PC.
    Fertil Steril; 2009 Aug; 92(2):499-507. PubMed ID: 18706551
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients.
    Al-Shawaf T, Zosmer A, Hussain S, Tozer A, Panay N, Wilson C, Lower AM, Grudzinskas JG.
    Hum Reprod; 2001 Jan; 16(1):24-30. PubMed ID: 11139531
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of coasting on cycle outcome during in vitro fertilization/intracytoplasmic sperm injection cycles in hyper-responders.
    Kovács P, Mátyás S, Kaali SG.
    Fertil Steril; 2006 Apr; 85(4):913-7. PubMed ID: 16580374
    [Abstract] [Full Text] [Related]

  • 12. The effect of withholding gonadotropin (a coasting period) on the outcome of in vitro fertilization cycles.
    Owj M, Tehrani Nejad ESh, Amirchaghmaghi E, Ezabadi Z, Baghestani AR.
    Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):81-5. PubMed ID: 17229513
    [Abstract] [Full Text] [Related]

  • 13. Premature Progesterone Elevation Does Not Affect Pregnancy Outcome in High-Responder Patients Undergoing Short-Interval Coasting in IVF Cycles.
    Acet M, Aktün LH, Başaranoğlu S, Yorgunlar B, Acet T, Deregözü A.
    Med Sci Monit Basic Res; 2015 Nov 30; 21():247-52. PubMed ID: 26634938
    [Abstract] [Full Text] [Related]

  • 14. Can the fall in serum FSH during coasting in IVF/ICSI predict clinical outcomes?
    Datta AK, Zosmer A, Tozer A, Sabatini L, Davis C, Al-Shawaf T.
    Reprod Biomed Online; 2012 May 30; 24(5):503-10. PubMed ID: 22417663
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ovarian hyperstimulation syndrome: steps to maximize success and minimize effect for assisted reproductive outcome.
    Gera PS, Tatpati LL, Allemand MC, Wentworth MA, Coddington CC.
    Fertil Steril; 2010 Jun 30; 94(1):173-8. PubMed ID: 19356753
    [Abstract] [Full Text] [Related]

  • 18. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile.
    Papanikolaou EG, Tournaye H, Verpoest W, Camus M, Vernaeve V, Van Steirteghem A, Devroey P.
    Hum Reprod; 2005 Mar 30; 20(3):636-41. PubMed ID: 15576388
    [Abstract] [Full Text] [Related]

  • 19. The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome.
    Tozer AJ, Iles RK, Iammarrone E, Gillott CM, Al-Shawaf T, Grudzinskas JG.
    Hum Reprod; 2004 Mar 30; 19(3):522-8. PubMed ID: 14998945
    [Abstract] [Full Text] [Related]

  • 20. Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome.
    Ragni G, Vegetti W, Riccaboni A, Engl B, Brigante C, Crosignani PG.
    Hum Reprod; 2005 Sep 30; 20(9):2421-5. PubMed ID: 15890731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.